In support of this, FOXC1 enhanced the DNA-binding ability of GLI2, evident by enhanced binding of GLI2 at the promoter of FAM38B gene, which is also markedly upregulated in breast cancer cells as a result of FOXC1 overexpression. The gene discussed is GLI2; the disease is breast carcinoma.